Kurtis Zinger

Cooley advised Red Canary, a top managed detection and response platform that investigate threats while streamlining workflows through automated remediation, on its acquisition by Zscaler (Nasdaq: ZS).

Cooley advised Tenet Medicines, a development-stage private biotechnology company, on its definitive agreement to be acquired by Eliem Therapeutics, a biotech company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems.

Cooley advised ColdQuanta, a global quantum technology company, on its $110 million Series B financing round. The company will use the capital to commercialize its product portfolio to include quantum computing, quantum algorithms and applications, atomic clocks, sensors and components. Partner Mike Nelson led the Cooley team advising ColdQuanta.

Cooley advised Velocity Global, a leading provider of global talent solutions, on its $400 million Series B financing round. With the fundraise, the company has achieved a multibillion-dollar valuation – a seven-fold increase since this time last year. Partners Laura Medina and Mike Nelson led the Cooley team advising Velocity Global.

Cooley advised Bolder Surgical, a privately held, US-based company that provides advanced energy vessel sealing surgical devices, on its sale to Hologic, a global leader in women’s health, for $160 million. Partner Laura Medina led the Cooley team advising Bolder Surgical. 

Read more